# Madan Jagasia

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/madan-jagasia/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,796 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 70 |
| i10-index | 193 |
| Last Known Institution | Barricaid (United States) |
| OpenAlex ID | https://openalex.org/A5070008988 |
| ORCID iD | https://orcid.org/0000-0001-5757-5604 |
| Works | 494 |

## Researcher papers

- [National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report](https://scholariq.org/papers/national-institutes-of-health-consensus-development-project-on-criteria-for/)
- [Risk factors for acute GVHD and survival after hematopoietic cell transplantation](https://scholariq.org/papers/risk-factors-for-acute-gvhd-and-survival-after-hematopoietic-cell/)
- [Ibrutinib for chronic graft-versus-host disease after failure of prior therapy](https://scholariq.org/papers/ibrutinib-for-chronic-graft-versus-host-disease-after-failure-of-prior-therapy/)
- [Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study](https://scholariq.org/papers/belumosudil-for-chronic-graft-versus-host-disease-after-2-or-more-prior-lines-of/)
- [Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study](https://scholariq.org/papers/efficacy-and-safety-of-lifileucel-a-one-time-autologous-tumor-infiltrating/)
- [Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/chronic-myeloid-leukemia-version-1-2019-nccn-clinical-practice-guidelines-in/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [Barricaid (United States)](https://scholariq.org/institutions/barricaid-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.